Epigenomic Mechanism of Parkinson's Disease
Epigenomic Mechanism of Parkinson's Disease
批准号:
8547489
负责人:
Xiongwei Zhu
金额:
$20.19万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-20 至 2016-08-31
关键词:
1-Methyl-4-phenylpyridiniumAffectAgeAgingAutopsyBrainCellsCytokine GeneDNA MethylationDataDiseaseDisease ProgressionEnvironmental Risk FactorEpigenetic ProcessFutureGene ExpressionGenesGeneticGenetic DeterminismHumanLevodopaLewy BodiesMediator of activation proteinMethodsMethylationMolecularMovementMovement DisordersMusNerve DegenerationNeurodegenerative DisordersNeuronsNeurotoxinsParkinson DiseaseParkinsonian DisordersPathogenesisPathway interactionsPatientsPatternPesticidesPlayReagentRegulationResearch PersonnelRisk FactorsRoleSeriesSignal PathwaySignal TransductionSiteSubstantia nigra structureTechniquesTestingToxic Environmental SubstancesTremoradult neurogenesisage relatedbasebrain tissuedopaminergic neurondosageepigenomicsgenome-wideinsightmind controlmouse modelneurogenesisnovelpars compactapreventpublic health relevancetherapeutic development
中文摘要
描述(由申请人提供):令人信服的证据表明,遗传因素和环境因素在PD的发病机制中起重要作用。在家族性PD中已鉴定出超过13个遗传位点。衰老和一些神经毒素,包括MPTP和某些杀虫剂,是人类帕金森病的已知危险因素。然而,疾病相关的环境因素,特别是它们与遗传因素在PD发病机制中的相互作用的潜在分子机制仍然知之甚少。表观遗传变化被认为是遗传决定因素与衰老或环境毒素之间的中介。在一项初步研究中,我们利用新的测序技术确定了一系列散发性PD患者和匹配良好的对照患者脑组织中80,000 - 110,000个高度信息化CpG位点的整体甲基化状态,我们发现参与神经发生的多个基因,特别是wnt信号通路中的基因,在PD脑中高度甲基化。与这一观点一致,用亚致死剂量MPP+处理的SH-SY 5 Y细胞的全基因组表达分析揭示了wnt途径中基因表达的降低,沿着细胞因子基因表达的增加。这些发现表明,特定的功能途径,如wnt途径,在PD的发病机制和进展过程中表观遗传失调。我们的初步结果支持了PD发病机制中的表观遗传调控的重要作用。基于这些令人兴奋的初步数据,我们假设环境风险因素通过(至少部分地)表观遗传相关机制显著促进PD的发生和进展。在这项研究中,我们建议确定PD患者大脑中DNA甲基化失调的功能途径。我们还将确定已知的环境毒素是否在小鼠模型中诱导DNA甲基化的类似变化。最后,我们将选择wnt通路作为目标,以确定其失调在PD发病机制中的作用,作为概念的证据。该研究的成功完成将为环境因素促进PD发病机制提供新的见解,并确定基因或途径作为未来开发治疗试剂的潜在靶点。
英文摘要
DESCRIPTION (provided by applicant): Compelling evidence suggests that both genetic factors and environmental factors play important roles in the pathogenesis of PD. Over 13 genetic loci have been identified in the familial forms of PD. Aging and a number of neurotoxins, including MPTP and certain pesticides, are known risk factors of human parkinsonia. However, the underlying molecular mechanism of the disease-associated environmental factors, particularly, their interaction with genetic factors in PD pathogenesis, remains poorly understood. It is thought that epigenetic changes are mediators between genetic determinants and aging or environmental toxins. In a preliminary study, we determined the global methylation status of 80,000-110,000 highly informative CpG sites in brain tissue from a series of sporadic PD patient and well-matched control patients utilizing novel sequencing technique and we found that multiple genes involved in neurogenesis, particularly the ones in the wnt signaling pathway, were hypermethylated in PD brains. Consistent with this notion, genome-wide expression analysis of SH-SY5Y cells treated with sub-lethal dosage of MPP+ revealed reduced expression of genes in wnt pathways along with increased expression of cytokine genes. These findings demonstrate that specific functional pathways, such as the wnt pathway, are epigenetically dysregulated during the pathogenesis and progression of PD. Our preliminary results support an important role of epigenetic regulation in PD pathogenesis. Based on these exciting preliminary data, we hypothesize that environmental risk factors contribute significantly to initiation and progression of PD via, at least partially, an epigenetic- involved mechanism. In this study, we propose to determine the functional pathways dysregulated by DNA methylation in PD patient brains. We will also determine whether known environmental toxins induce similar changes of DNA methylation in mouse models. Finally, we will select the wnt pathway as a target to determine the role of its dysregulation in the pathogenesis of PD as proof of concept. Successful completion of the study will provide novel insights into the mechanisms through which environmental factors contribute to PD pathogenesis and identify genes or pathways as potential targets for future development of therapeutic reagents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Mettl3-dependent RNA m6A dysregulation in Alzheimer's disease
-
批准号:10739065
-
项目类别:
-
资助金额:$215.63万
-
财政年份:2023
-
负责人:Xiongwei Zhu
-
依托单位:
Research Education Component
-
批准号:10474608
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2021
-
负责人:Xiongwei Zhu
-
依托单位:
Research Education Component
-
批准号:10675675
-
项目类别:
-
资助金额:$39.86万
-
财政年份:2021
-
负责人:Xiongwei Zhu
-
依托单位:
Research Education Component
-
批准号:10263716
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2021
-
负责人:Xiongwei Zhu
-
依托单位:
Epigenomic Mechanism of Parkinson's Disease
-
批准号:8738730
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
-
批准号:9261605
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:10614554
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
-
批准号:8829930
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:8869054
-
项目类别:
-
资助金额:$9.17万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:10213144
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:9085404
-
项目类别:
-
资助金额:$9.26万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:10425313
-
项目类别:
-
资助金额:$15.68万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:9302851
-
项目类别:
-
资助金额:$8.07万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
-
批准号:8607355
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
-
批准号:8689195
-
项目类别:
-
资助金额:$41.11万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
LRRK2 and mitochondrial dysfunction
-
批准号:8130881
-
项目类别:
-
资助金额:$23.08万
-
财政年份:2010
-
负责人:Xiongwei Zhu
-
依托单位:
LRRK2 and mitochondrial dysfunction
-
批准号:8048530
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2010
-
负责人:Xiongwei Zhu
-
依托单位:
Mitochondrial Fission and Fusion in Alzheimer Disease
-
批准号:7800269
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2008
-
负责人:Xiongwei Zhu
-
依托单位:
Mitochondrial Fission and Fusion in Alzheimer Disease
-
批准号:8230562
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2008
-
负责人:Xiongwei Zhu
-
依托单位:
Mitochondrial Fission and Fusion in Alzheimer Disease
-
批准号:7439456
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2008
-
负责人:Xiongwei Zhu
-
依托单位:
海外基金